Stavudine - stavudine
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-5041 |
| Proprietary Name: | Stavudine |
| Suffix: | |
| Non-Proprietary Name: | stavudine |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 10-02-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA079069 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | STAVUDINE |
| Active Numerator Strength: | 20 |
| Active Ingredient Unit: | mg/1 |
| Pharm Classes: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| DEA Schedule: |